Sulfone compounds which modulate the CB2 receptor

US8178568B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• John R. Regan · Princeton, US
• Doris Riether · Biberach an der Riß, DE

Key dates

• Filing date: Jun 24, 2009
• Grant date: May 15, 2012
• Expiry date: Jun 24, 2029

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds which modulate the CB2 receptor are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.